Interventions for Individuals With Fetal Alcohol Syndrome: Transitioning Science to Community Projects, 18400-18405 [05-7147]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 70, Number 68 (Monday, April 11, 2005)]
[Notices]
[Pages 18400-18405]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7147]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Interventions for Individuals With Fetal Alcohol Syndrome: 
Transitioning Science to Community Projects

    Announcement Type: New.
    Funding Opportunity Number: RFA DD05-079.
    Catalog of Federal Domestic Assistance Number: 93.283.
    Key Dates:
    Application Deadline: May 26, 2005.

I. Funding Opportunity Description

    Authority: This program is authorized under Sections 317(k)(2) 
and 317C of the Public Health Service Act, (42 U.S.C. 247b(k)(2) and 
247b-(4), as amended.
Purpose:
    The purpose of this cooperative agreement is to implement the 
continuation of a directive within the Children's Health Act of 2000 to 
develop and scientifically evaluate interventions for children and 
adolescents affected by Fetal Alcohol Syndrome (FAS) or other 
conditions resulting from prenatal alcohol exposure and their families. 
Interventions were developed to (1) improve developmental outcomes, (2) 
prevent secondary conditions, and (3) provide education and support to 
caregivers and families. The primary objective of this program is to 
translate successful or promising scientifically evaluated 
interventions for children with FAS to community settings.
    This program addresses the ``Healthy People 2010'' focus areas of 
Substance Abuse and Maternal, Infant, and Child Health.
    Measurable outcomes of the program will be in alignment with FAS-
related performance goals for the National Center on Birth Defects and 
Developmental Disabilities that include establishing new, or enhancing 
existing prevention programs designed to reduce the prevalence of FAS, 
reduce prenatal exposure to alcohol, and improve and/or link children 
currently affected by FAS to health services.
Research Objectives and Background
    Development of interventions and public health programs often occur 
in large research-oriented medical schools and universities. These 
settings provide a large number of intellectual and logistical 
resources that facilitate development of state-of-the-art interventions 
and programs. Frequently however, developed programs are

[[Page 18401]]

simply released to community agencies who must determine how best to 
adapt and implement the programs; otherwise the interventions languish 
in scientific journals without community implementation. This program 
seeks to bridge the transition between research-based development of 
interventions and community implementation of these interventions.
    The benefit of intervention, especially early intervention, for 
individuals with developmental disabilities has long been proven in the 
scientific and community programs literatures. Until recently, 
information and strategies for interventions specific to individuals 
with FAS has been gleaned from other disabilities, and the wisdom 
gained by parents has been achieved through trial and error and shared 
through informal networks. Although informative to a limited degree, 
such treatments have been implemented without being evaluated 
systematically or scientifically.
    To increase scientific understanding of the spectrum of disorders 
associated with prenatal alcohol exposure, recipients should develop 
mechanisms to obtain neuro-development assessment data from children 
participating in the community-based interventions, and estimate and 
compare economic costs and benefits of prescribed interventions in the 
community setting.
    Hence, the approach of the current cooperative agreement (RFA DD05-
079) will be for each funded site to work with a community agency to 
adapt their program to the community setting. In the later stages of 
the program, each site will document the intervention process such as 
through a working manual or guidance, and initiate a train-the-trainer 
type program to facilitate even broader dissemination of these 
scientifically evaluated interventions for children with FAS.
    In 2001, CDC provided the first federal funding to develop 
systematic, specific, and scientifically evaluated interventions 
appropriate for children with FAS and their families.
    Under that competitive announcement, awards were made to five 
recipients to conduct interventions with the aim of improving the 
developmental outcomes of individuals with FAS, reducing secondary 
conditions, and improving the lives of families affected by FAS.
    For each site, children in both treatment and control groups 
received comprehensive multi-disciplinary assessments that guided 
referrals for standard care and services as indicated (e.g., speech 
therapy, special education). Beyond assessment and standard care, 
children in the treatment groups also received interventions 
specifically designed to focus on one of the core vulnerabilities 
associated with FAS: mathematical skills, social communication, peer 
relations, foster care stability, compliance, learning readiness, and 
challenging behaviors. All sites included specific instruction and 
training for parents and caregivers as part of the treatment process. 
Final analyses and submission of articles to scientific journals is 
anticipated in late 2005.
    Thus, this announcement seeks to build upon previous activities and 
foundation building in partnering with community agencies, employing a 
study design to include outcome assessment data and documenting 
performance toward process and time-bounded objectives, and 
implementing a dissemination program to publicize approaches, 
collaborations, and results.
    In effect, these five recipients should have completed or be 
nearing completion of intervention research that has: Concluded data 
collection; completed or is advanced in data analysis; measured 
behavioral and/or health outcomes related to intervention(s) for 
individuals with prenatal alcohol exposure; collected pre- and post-
test data, used treatment and control/comparison groups with random 
assignment; and evaluated the effectiveness of intervention(s) using 
quantitative statistics.
Activities
    Project activities should focus on tailoring and adapting a proven 
intervention to community settings and facilitating start-up 
activities. Awardee activities for this program are as follows:
    1. Translate scientifically evaluated interventions for children 
with a Fetal Alcohol Syndrome Disorder (FASD) for use in community 
settings through partnership with a community agency (e.g., school, 
health department, state service organization) and to adapt each 
intervention to the resources; infrastructure, and personnel of their 
partner;
    2. Demonstrate the utility and scientific credibility of developed 
materials and training of community agencies for implementing these 
interventions toward enhancing cognitive, developmental, or behavioral 
outcomes for children with FASD;
    3. Work with partner agency to develop outreach and recruitment 
procedures for identification of affected children and their families 
from multiple sources to maximize the possibility of ascertaining 
participants;
    4. Develop mechanisms to identify core elements of intervention 
necessary to ensure fidelity of implementation;
    5. Disseminate these scientifically evaluated and proven credible 
interventions for children with FAS by development of a train-the-
trainer or other similar programs to be offered to appropriate 
professionals (e.g., medical and allied health, education, case 
managers, etc);
    6. Facilitate definition of the full spectrum of neuro-
developmental disabilities associated with prenatal exposure to alcohol 
and its consequences by development of a cross-site collaborative 
database including: (a) Neuro-developmental testing results for 
children with FAS or other prenatal alcohol exposure related conditions 
in the community setting; and (b) outcomes;
    7. Subsequent to definition of variables to be included in 
development of the database and the convening of investigators from 
other funded projects, discuss and develop a common protocol that could 
be implemented for obtaining assessment data from children, and in 
determining outcomes, costs and benefits of each intervention;
    8. Prepare scientific reports for publication that document the 
translated research study findings. The dissemination effort should 
seek to convert interventions into packages of ``how to'' materials for 
use in community settings for implementing the target intervention.
CDC Responsibilities
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring. In 
this cooperative agreement, CDC Scientists (Scientific Collaborator) 
within the National Center on Birth Defects and Developmental 
Disabilities (NCBDDD) are an equal partner with scientific and 
programmatic involvement during the conduct of the project through 
technical assistance, advice, and coordination. Scientific 
Collaborators will:
    1. Use their experience in studies of this nature to advise the 
project on specific questions regarding the project-developed protocol;
    2. As requested, assist the project in responding to inquiries 
regarding such areas as data management, data analysis, intervention 
design, family dynamics, formats for presenting research findings, and 
in comparing project-developed evaluation formats with other research 
projects and activities known to CDC;
    3. Provide scientific consultation and technical assistance as 
requested on questions related to epidemiology,

[[Page 18402]]

statistical and power calculations, and data storage and tracking 
formats used in other CDC sponsored research that could be advantageous 
to the project; and
    4. Suggest to the project upon request; processes for analysis, 
interpretation, and reporting of findings in the literature that can 
serve a broad range of scientific interests.

CDC Scientific Program Administrator (SPA)

    The CDC NCBDDD will appoint an SPA, apart from the NCBDDD 
Scientific Collaborator who will:
    1. Serve as the Program Official for the funded research 
institutions.
    2. Carry out continuous review of all activities to ensure 
objectives are being met.
    3. Attend Coordinating Committee meetings for purposes of assessing 
overall progress and for program evaluation purposes.
    4. Provide scientific consultation and technical assistance in the 
conduct of the project as requested.
    5. Conduct site visits to recipient institutions to determine the 
adequacy of the research and to monitor performance against approved 
project objectives.

Collaborative Responsibilities

    The planning and implementation of the cooperative aspects of the 
study will be effected by a coordinating committee consisting of the 
Principal Investigator from the organizations receiving awards under 
this program and the CDC Scientific Collaborator. Organizations serving 
as sub-contractors under awarded projects are not considered members of 
the coordinating committee. This coordinating committee will formulate 
a plan for cooperative research and address issues of common concern 
throughout the life of the project.
    At periodic coordination committee meetings, the group will: (1) 
Make recommendations on the study protocol and data collection 
approaches; (2) discuss common protocols as they relate to neuro-
development assessment data from children participating in community-
based interventions, development of a cross-site collaborative database 
of testing results, and collecting cost estimates for each 
intervention; (3) discuss the target populations that have been or will 
be recruited; (4) identify and recommend solutions to unexpected study 
problems; and (5) discuss ways to efficiently coordinate study 
activities and best practices.

II. Award Information

    Type of Award: Cooperative agreement.
    CDC involvement in this program is listed in the Activities Section 
above.
    Mechanism of Support: U84 (The Administrative Code for FAS 
cooperative agreements).
    Fiscal Year Funds: 2005.
    Approximate Total Funding: $1,500,000. The estimated funding amount 
is pending availability of FY 2005 funds, and is subject to change.
    Approximate Number of Awards: Five.
    Approximate Average Award: $300,000. This amount is for the first 
12-month budget period for each of the five awarded projects, and 
includes both direct and indirect costs.
    Floor of Award Range: $300,000.
    Ceiling of Award Range: $300,000.
    Anticipated Award Date: August 1, 2005.
    Budget Period Length: 12 months.
    Project Period Length: Four Years. Throughout the project period, 
CDC's commitment to continuation of awards will be conditioned on the 
availability of funds, evidence of satisfactory progress by the 
recipient (as documented in required reports), and the determination 
that continued funding is in the best interest of the Federal 
government.

III. Eligibility Information

III.I. Eligible Applicants

    Eligibility is limited to those projects previously funded under 
CDC Program Announcement Number 01074; FAS Neuro-development Disorders 
in Children and/or Adolescents. They include the University of 
California, Los Angeles; Children's Research Triangle, Chicago, IL; 
Kennedy Krieger Institute, Baltimore, MD (with the project located at 
the Marcus Institute in Atlanta, GA); University of Oklahoma Health 
Sciences Center; and the University of Washington. This limited 
eligibility is based on sustaining support to well-established 
projects, and to take advantage of the foundation and multiple systems 
developed over time and now in place to identify and impact on the 
lives of individuals with FAS and their families.

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    If you request a funding level greater than the upper threshold, 
your application will not be eligible for review. You will be notified 
that you did not meet submission requirements.
Special Requirements
    If your application is incomplete or non-responsive to the 
requirements listed below, it will not be entered into the review 
process. You will be notified that your application did not meet 
submission requirements.
    Applicants must document their present infrastructure, capacity, 
expertise, and experience (within organization or within organizations 
of collaborators) in conducting research directly related to the 
awardee activities cited in this announcement.

    Note: Title 2 of the United States Code Section 1611 states that 
an organization described in Section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

    Individuals Eligible to Become Principal Investigators: Any 
individual with the skills, knowledge, and resources necessary to carry 
out the proposed research is invited to work with their institution to 
develop an application for support. Individuals from under-represented 
racial and ethnic groups as well as individuals with disabilities are 
always encouraged to apply for CDC programs.

IV. Application and Submission Information

IV.1 Address To Request Application Package

    To apply for this funding opportunity, use application form PHS 398 
(OMB number 0925-0001 rev. 11/2004). Forms and instructions are 
available in an interactive format on the CDC Web site, at the 
following Internet address: https://www.cdc.gov/od/pgo/forminfo.htm.
    Forms and instructions are also available in an interactive format 
on the National Institutes of Health (NIH) Web site at the following 
Internet address: https://grants.nih.gov/grants/funding/phs398/
phs398.html.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Application Submission

    Application: Follow the PHS 398 application instructions for 
content and formatting of your application. If the instructions in this 
announcement differ in any way from the PHS 398 instructions, follow 
the instructions in this announcement. For further

[[Page 18403]]

assistance with the PHS 398 application form, contact PGO-TIM staff at 
(770) 488-2700, or contact Grants Info, Telephone (301) 435-0714, E-
mail: GrantsInfo@nih.gov.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. Your DUNS number must be entered 
on line 11 of the face page of the PHS 398 application form. The DUNS 
number is a nine-digit identification number, which uniquely identifies 
business entities. Obtaining a DUNS number is easy and there is no 
charge. To obtain a DUNS number, access www.dunandbradstreet.com or 
call 1-866-705-5711. For more information, see the CDC Web site at: 
https://www.cdc.gov/od/pgo/funding/pubcommt.htm.
    This announcement uses the non-modular budgeting format. See: 
https://grants.nih.gov/grants/funding/modular/modular.htm.
    The PHS 398 grant application form requires the applicant to enter 
the project title on page 1 (Form AA, ``Face Page'') and the project 
description (abstract on page 2).
    The main body of the application narrative should not exceed 25 
single-spaced pages. This narrative research plan should address 
activities to be conducted over the entire project period.
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit. This additional information may include curriculum vitae 
and r[eacute]sum[eacute]s for key project staff, organizational charts, 
letters of commitment and support, graphic work plan with time 
intervals related to goals and objectives, etc.; and should be limited 
to those items relevant to the requirements of this announcement. 
Applicants must provide a graphic work plan that outlines major goals 
and objectives with timelines established for each calendar quarter 
covering the entire project period.
    All material must be typewritten, with 10 characters per inch type 
(12 point) on 8 -\1/2\ by 11 inch white paper with one inch margins, no 
headers or footers (except for applicant-produced forms such as 
organizational charts, c. vitae, graphs and tables, etc). Applications 
must be held together only by rubber bands or metal clips, and not 
bound together in anyway (including attachments/appendices).
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Time

    Application Deadline Date: May 26, 2005.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline 
date. If you send your application by the appropriate postal service or 
commercial delivery service, you must ensure that the carrier will be 
able to guarantee delivery of the application by the closing date and 
time. If CDC receives your application after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carrier's guarantee. If the documentation 
verifies a carrier problem, CDC will consider the application as having 
been received by the deadline.
    This announcement is the definitive guide on the application 
submission address and deadline. It supersedes information provided in 
the application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that your application did not meet the 
submission requirements.
    CDC will not notify you upon receipt of your submission. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the submission deadline. This will allow time for submissions to be 
processed and logged.

IV.4. Intergovernmental Review of Applications

    Executive Order 12372 does not apply to this program.

IV.5. Funding Restrictions

    Restrictions, which must be taken into account while writing your 
budget are:
     Project funds cannot be used to supplant other available 
applicant or collaborating agency funds for construction or for lease 
or purchase of facilities or space.
     Funds may be spent for reasonable program purposes, 
including personnel, travel, supplies, and services. Equipment may be 
purchased if deemed necessary to accomplish program objectives, 
however, prior approval by CDC officials must be requested in writing.
     The applicant may contract with other organizations under 
this program; however the applicant must perform a substantial portion 
of the activities (including program management and operations, and 
delivery of prevention services for which funds are required).
     If you are requesting indirect costs in your budget, you 
must include a copy of your indirect cost rate agreement. If your 
indirect cost rate is a provisional rate, the agreement must be less 
than 12 months from the application due date.

IV.6. Other Submission Requirements

    Application Submission Address: Submit the original and one hard 
copy of your application by mail or express delivery service to: 
Technical Information Management--RFA DD05-079, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, Georgia 30341.
    At the time of submission, four additional copies of the 
application, and all appendices must be sent via overnight commercial 
carrier to: Dr. Kathleen Madden, Office of Public Health Research 
(OPHR), 1 West Court Square, Suite 7000, Room 7008, Mailstop D-72, 
Decatur, Georgia 30030, E-mail address: kmn0@cdc.gov.

V. Application Review Information:

V.1. Criteria

    You are required to provide measures of outcome and effectiveness 
that will demonstrate the accomplishment of the various identified 
objectives for each stage of the cooperative agreement. Measures of 
effectiveness must relate to the performance goals stated in the 
``Purpose'' section of this announcement. Measures must be objective 
and quantitative, and must measure the intended outcome. These measures 
of effectiveness must be submitted with the application and will be an 
element of evaluation.
    In the written comments, reviewers will be asked to evaluate the 
application in order to judge the likelihood that the proposed research 
will have a substantial impact on the pursuit of these goals. The 
scientific review group will address the applications' overall score, 
weighting them as appropriate for each application. The application 
does not need to be strong in all categories to be judged likely to 
have major scientific impact and thus deserve a high priority score.
    Under the evaluation criteria noted below, applicants must describe 
how they will address the program components as they relate to the

[[Page 18404]]

Purpose and Research Objectives, and Recipient Activities as cited in 
this Announcement.
    Your application will be evaluated against the following criteria. 
Please ensure that your narrative describes not only what will be done, 
but how and through what tasks and activities the work will be 
undertaken:
    1. Resources and Organizational Capacity, including but not limited 
to applicant experience, within its organization and with collaborating 
partners to meet all the requirements of this announcement; and a 
demonstrated ability to assemble a team with the experience and time 
commitments to dedicate full attention to all planning, implementation, 
and outcome assessment components of the project.
    2. Methods and Activities, including but not limited to ensuring 
that proposed methods and activities convincingly and comprehensively 
meet the intention and goals of the announcement; that the methods and 
activities are feasible within scientific, programmatic and fiscal 
constraints and will produce accurate, valid and reliable data; that 
the calculated statistical power and the potential capacity of the 
research design is adequate to generate meaningful results during the 
study period; and that the design can be easily replicated for future 
use by sponsoring organizations including the dissemination of findings 
and recommendations for the benefit of other agencies.
    3. Management, Staffing, and Objectives, including evidence that 
the applicant has sufficient scientific and management resources for 
project planning and data management/analysis; that the proposed 
staffing, staff qualifications, experience, and project organization 
are sufficient to accomplish the objectives of the program; and that 
the project goals and objectives can be accomplished through the 
proposed methods and within the proposed timeline.
    4. Evaluation Plan, including that the evaluation components 
described in the announcement have been addressed in the proposal; that 
the measurable objectives included in the methods proposed are 
appropriate for the measurable objectives; and that the evaluation plan 
includes a process for overall evaluation of sub-components and the 
entire project, including the assignment of responsibility for ongoing 
review of all specified components.
    5. Budget Description and Justification, including the 
comprehensiveness and adequacy of the proposed budget in relation to 
program operations, collaborations, and services; and the extent to 
which the budget is reasonable, clearly justified, accurate, and 
consistent with the purposes of this research.
    6. Protections: Does the application adequately address the 
requirements of 45 CFR Part 46 for the protection of human subjects? 
This criteria will not be scored; however, an application can be 
disapproved if the research risks are sufficiently serious and 
protection against risks is so inadequate as to make the entire 
application unacceptable.
    7. Inclusion: Does the application adequately address the CDC 
policy requirements regarding the inclusion of women, ethnic, and 
racial groups in the proposed research? This includes:
    a. The proposed plan for the inclusion of both sexes and racial and 
ethnic minority populations for appropriate representation.
    b. The proposed justification when representation is limited or 
absent.
    c. A statement as to whether the design of the study is adequate to 
measure differences when warranted.
    d. A statement as to whether the plans for recruitment and outreach 
for study participants include the process of establishing partnerships 
with community(ies) and recognition of mutual benefits.

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) and for responsiveness by OPHR. Incomplete 
applications and applications that are non-responsive as to the 
eligibility criteria and other eligibility requirements will not 
advance through the review process. Applicants will be notified that 
their application did not meet submission requirements and will not 
receive further consideration.
    Applications, which are complete and responsive, will be subjected 
to a preliminary evaluation (triage) by the scientific review group 
(Special Emphasis Panel--SEP) composed of external (non-CDC) peer 
reviewers to determine if the application is of sufficient technical 
and scientific merit to warrant further review by the SEP. Applications 
that are determined to be non-competitive will not be considered. 
Subsequent to the review meeting CDC will notify the investigator/
program director and the official signing for the applicant 
organization of that determination.
    Applications determined to be competitive will then be reviewed and 
scored under the formal SEP peer review process. The review of these 
fully competitive applications will result in the determination of the 
score and ranking for those applications.
    Subsequent to the formal peer review by the SEP, a second level of 
review will be conducted by senior CDC program staff. This review is 
not intended to revisit the scientific merit of the applications. It is 
designed to review and discuss issues related to the adequacy and 
justification of the proposed budgets and funding ceilings, and to 
review the overall rating and ranking of all recommended applications. 
This will be done in order to prepare recommendations for funding based 
on the scientific merit as determined by the SEP; and to ensure that 
the recommendations are consistent and compatible with the Review and 
Selection section of the original program announcement.
    V.3. Anticipated Award Date:
    August 1, 2005.

VI. Award Administration Information

    VI.1. Award Notices: If your application is to be funded, you will 
receive a Notice of Award (NoA) from the CDC Procurement and Grants 
Office. The NoA shall be the only binding, authorizing document between 
the recipient and CDC. The NoA will be signed by an authorized Grants 
Management Officer and mailed to the recipient fiscal officer 
identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

    45 CFR Parts 74 and 92.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: https://www.access.gpo.gov/nara/cfr/cfr-table-search.html. The 
following additional requirements apply to this project:

 AR-1: Human Subjects Requirements
 AR-2: Requirement for Inclusion of Women and Racial and Ethnic 
Minorities in Research
 AR-10: Smoke-Free Workplace Requirements
 AR-11: Healthy People 2010
 AR-12: Lobbying Restrictions
 AR-22: Research Integrity
 AR-25: Release and Sharing of Data

    Projects that involve the collection of information from 10 or more 
individuals and funded by cooperative agreement will be subject to 
review by the Office of Management and Budget under the Paperwork 
Reduction Act.
    Additional information on these requirements can be found on the 
CDC

[[Page 18405]]

web site at the following Internet address: https://www.cdc.gov/od/pgo/
funding/ARs.htm.

VI.3. Reporting

    You must provide CDC with an original, plus two copies of the 
following reports:
    1. Interim progress report, (PHS 2590, OMB Number 0925-0001, rev. 
11/2004), on a date to be determined for your project for each 
subsequent budget year. The progress report will serve as your non-
competing continuation application, and must contain the following 
elements:
    a. Current Budget Period Activities and Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activities and Objectives.
    d. Budget.
    e. Additional Requested Information.
    f. Measures of Effectiveness.
    2. Financial status report and annual report, no more than 90 days 
after the end of the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be sent to the Grants Management Specialist 
listed in the ``Agency Contacts'' section of this announcement.

VII. Agency Contacts

    We encourage inquiries concerning this announcement. For general 
questions contact: Technical Information Management Section (PGO-TIM), 
CDC Procurement and Grants Office, 2920 Brandywine Road, Atlanta, 
Georgia 30341, Telephone: 770-488-2700.
    For program technical assistance, contact: Don Lollar, Ed.D., 
National Center on Birth Defects and Developmental Disabilities, CDC, 
1600 Clifton Road, Mailstop E-87, Atlanta, Georgia 30333, E-Mail 
Address: dlollar@cdc.gov. Telephone: 404-498-3041.
    For budget assistance, contact: Nealean Austin, Grants Management 
Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road, 
Atlanta, Georgia 30341, Telephone: 770-488-2814, E-mail: 
naustin@cdc.gov.

VIII. Other Information

    This and other CDC funding opportunity announcements can be found 
on the CDC web site, Internet address: https://www.cdc.gov. Click on 
``Funding'' then ``Grants and Cooperative Agreements.''

    Dated: April 5, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-7147 Filed 4-8-05; 8:45 am]
BILLING CODE 4163-18-P